Addus HomeCare (ADUS) Form 144 Filed for 1,571 Common Shares Sale
Rhea-AI Filing Summary
Addus HomeCare Corp. (ADUS) filing a Form 144 notifies the proposed sale of 1,571 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $180,555.03 and an approximate sale date of 08/19/2025 on NASDAQ. The filer reports total outstanding shares of 18,407,239. The shares were acquired as restricted stock in three tranches: 1,013 on 06/12/2025, 104 on 06/16/2022, and 454 on 06/15/2021. The filing contains no reported sales in the past three months and includes the standard attestation about material nonpublic information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider sale; negligible dilution relative to outstanding shares.
The proposed sale of 1,571 shares equals approximately 0.0085% of the reported 18,407,239 outstanding shares, indicating the transaction is immaterial to market capitalization. Aggregate value reported is $180,555.03, implying a per-share figure consistent with the stated market value. No recent sales in the past three months are reported, and acquisitions were via restricted stock grants across 2021, 2022 and 2025, which suggests these are routine equity compensation dispositions rather than a large executive exit.
TL;DR: Filing appears procedurally complete for a Rule 144 notice with broker and acquisition details disclosed.
The form identifies the executing broker, intended exchange (NASDAQ) and provides dates and nature of acquisition